Heterologous immunity and the nonspecific effects of vaccines: A major medical advance?

Pediatric Infectious Disease Journal

Volumn 23, Issue 6, 2004, Pages 555-558

  Shann, Frank ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Heterologous immunity; Nonspecific effects; Vaccines

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ANTIBODY RESPONSE; BCG VACCINATION; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; DEVELOPING COUNTRY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION PREVENTION; LOW BIRTH WEIGHT; MALE; MEASLES VACCINATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADOLESCENT; ANTIGENS, HETEROPHILE; BACTERIAL VACCINES; BCG VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNICABLE DISEASE CONTROL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FORECASTING; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; VACCINATION; VIRAL VACCINES;

EID: 3042548124     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000130155.42392.04     Document Type: Review

References (30)

1. + effector T cells. J Immunol. 2001;167:1379-1386.
2. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol. 2002;2:417-426.
3. Chen HG, Fraire AE, Joris I, et al. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol. 2003;163:1341-1355.
4. Aaby P, Samb B, Simondon, et al. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ. 1995;311:481-485.
5. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ. 2000;321:1435-1441.
6. Aaby P, Jensen H, Samb B, et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diptheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet. 2003;361:2183-2188.
7. Aaby P, Jensen H, Rodrigues A, et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol. 2004;33:367-373.
8. Aaby P, Jensen H, Garly ML, Balé C, Martins C, Lisse I. Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine. 2002;21:15-20.
9. Aaby P, Bhuyia A, Nahar L, Knudsen K, Francisco A, Strong M. The survival benefit of measles immunisation may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol. 2003;32:106-115.
10. Aaby P, Jensen H, Gomes J, Fernandes M, Lisse IM. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol. 2004;33:374-380.
11. Medical Research Council. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescents. BMJ. 1959;3:379-396.
12. Velema JP, Alihonou EM, Gandaho T, Hounye FH. Childhood mortality among users and non-users of primary health care in a rural West African community. Int J Epidemiol. 1991;20:474-479.
13. Niobey FML, Duchiade MP, Vasconcelos AGG, et al. Risk factors for death by pneumonia among children under one year of age in a metropolitan area of Southeastern Brazil: a case-control study. Rev Saude Publica. 1992;26:229-238.
14. Marchant A, Goetghebuer T, Ota M, et al. Newborns develop a T helper I type response to BCG vaccination. J Immunol. 1999;163:2249-2255.
15. Pabst HF, Spady DW, Carson MM, et al. Kinetics of immunologic responses after primary MMR vacination. Vaccine. 1997;15:10-14.
16. Lindblad EB, Elhay MJ, Silva R, et al. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun. 1997;65:623-629.
17. Lisse ID, Aaby P, Whittle H, et al. T-lymphocyte subsets in West African children: impact of age, sex and season. J Pediatr. 1997;130: 77-85.
18. Clark IA, Allison AC, Cox FE. Protection of mice against Babesia and Plasmodium with BCG. Nature. 1976;259:309-311.
19. Fine P. Commentary: an unexpected finding that needs confirmation or rejection. BMJ. 2000;321:7.
20. World Health Organization. Potential adverse impact of routine vaccination on child survival. Bull World Health Organ. 2002;47:393-394.
21. Cutts FT, Fine PEM. Caution: mortality ratios ahead. Lancet. 2003;361: 2169-2170.
22. Cooper WO, Boyce TG, Wright PF, Griffin MR. Do childhood vaccines have non-specific effects on mortality? Bull World Health Organ. 2003;81:821-826.
23. Kasongo Project Team. Influence of measles vaccination on survival pattern of 7-35-month-old children in Kasongo, Zaire. Lancet. 1981;1: 764-767.
24. Koenig MA, Khan MA, Wojtyniak B, et al. Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull WHO. 1990;68: 441-447.
25. Aaby P, Jensen H. Routine vaccination and child survival in Guinea-Bissau: authors' reply to commentary. BMJ. 2001;322:360.
26. Aaby P, Garly M, Bale C, et al. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Pediatr Infect Dis J. 2003;22:798-805.
27. Hartfield J, Obst D, Morley D. Efficacy of measles vaccine. J Hyg Camb. 1963;61:143-147.
28. Libman MD, Ibrahim SA, Omer MI, et al. No evidence for short or long term morbidity after increased titer measles vaccination in Sudan. Pediatr Infect Dis J. 2002;21:112-119.
29. Roth A, Jensen H, Garly M, et al. Should low birth weight infants receive BCG vaccination at birth? Community study from Guinea-Bissau. Pediatr Infect Dis J. 2004;23:000-000.
30. Aprile MA, Wardlaw AC. Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health. 1966;57: 343-354.